posted on 2023-03-02, 20:25authored byElizabeth A Pyatak, Donna Spruijt-Metz, Stefan Schneider, Raymond Hernandez, Loree T. Pham, Claire J. Hoogendoorn, Anne L Peters, Jill Crandall, Haomiao Jin, Pey-Jiuan Lee, Jeffrey S. Gonzalez
<p> </p>
<p>Objective: While there is evidence that functioning, or ability to perform daily life activities, can be adversely influenced by type 1 diabetes, the impact of acute fluctuations in glucose levels on functioning is poorly understood. </p>
<p>Research Design and Methods: Using dynamic structural equation modeling, we examined whether overnight glucose (CV, % time <70 mg/dL, % time >250 mg/dL) predicted 7 next-day functioning outcomes (mobile cognitive tasks, accelerometry-derived physical activity, self-reported activity participation) in adults with type 1 diabetes. We examined mediation, moderation, and whether short-term relationships were predictive of global patient-reported outcomes.</p>
<p>Results: Overall next-day functioning was significantly predicted from overnight CV (<em>p</em>=0.017) and % time >250 mg/dL (<em>p</em>=0.037). Pairwise tests indicated that higher CV was associated with poorer sustained attention (<em>p</em>=0.028) and lower engagement in demanding activities (<em>p</em>=0.028); time <70 mg/dL was associated with poorer sustained attention (<em>p</em>=0.007); and time >250 mg/dL was associated with more sedentary time (<em>p</em>=0.024). The impact of CV on sustained attention was partially mediated by sleep fragmentation. Individual differences in the effect of overnight time <70 mg/dL on sustained attention predicted global illness intrusiveness (<em>p</em>=0.016) and diabetes-related quality of life (<em>p</em>=0.036).</p>
<p>Conclusions: Overnight glucose predicts problems with objective and self-reported next-day functioning, and can adversely impact global patient-reported outcomes. These findings across diverse outcomes highlight the wide-ranging effects of glucose fluctuations on functioning in adults with type 1 diabetes.</p>
Funding
Abbott Diabetes Care
U.S. Department of Health and Human Services > National Institutes of Health > National Center for Advancing Translational Sciences UL1TR000130 UL1TR001855
U.S. Department of Health and Human Services > National Institutes of Health > National Institute of Diabetes and Digestive and Kidney Diseases 1R01DK121298-01 P30DK020541 P30DK111022
U.S. Department of Health and Human Services > National Institutes of Health > National Institute on Aging 1U2CAG060408